Survey of practicing cardiologists in maryland on their choice of thrombolytic therapy for acute myocardial infarction

Gary D. Plotnick, Andrew A. Ziskind, Robert A. Vogel

Research output: Contribution to journalArticle

Abstract

In November 1990, we surveyed 160 practicing community cardiologists in the state of Maryland and 20 academic cardiologists at the University of Maryland Medical Center to determine each individual's preference for aggressive versus nonaggressive therapy for various presentations of acute myocardial infarction. The survey was repeated in April 1991 following a report of the results of the Third International Study of Infarct Survival. All 100 responding cardiologists chose aggressive therapy to manage an early (<2 hours) acute anterior myocardial infarction in a 50-yearold patient. However, less aggressive therapy was chosen by many community cardiologists for management of early inferior acute myocardial infarction or for elderly patients. Most community cardiologists chose tissue plasminogen activator as their thrombolytic drug of choice, whereas university cardiologists favored streptokinase. Although there were substantial shifts in choice of thrombolytic agent on the repeat survey, most community physicians still chose tissue plasminogen activator over the less expensive streptokinase.

Original languageEnglish (US)
Pages (from-to)327-330
Number of pages4
JournalThe American Journal of Cardiology
Volume69
Issue number4
DOIs
StatePublished - Feb 1 1992
Externally publishedYes

Fingerprint

Thrombolytic Therapy
Myocardial Infarction
Streptokinase
Fibrinolytic Agents
Tissue Plasminogen Activator
Inferior Wall Myocardial Infarction
Surveys and Questionnaires
Cardiologists
Therapeutics
Physicians
Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Survey of practicing cardiologists in maryland on their choice of thrombolytic therapy for acute myocardial infarction. / Plotnick, Gary D.; Ziskind, Andrew A.; Vogel, Robert A.

In: The American Journal of Cardiology, Vol. 69, No. 4, 01.02.1992, p. 327-330.

Research output: Contribution to journalArticle

Plotnick, Gary D. ; Ziskind, Andrew A. ; Vogel, Robert A. / Survey of practicing cardiologists in maryland on their choice of thrombolytic therapy for acute myocardial infarction. In: The American Journal of Cardiology. 1992 ; Vol. 69, No. 4. pp. 327-330.
@article{4e8c88260f5045e09226fce43c2a1c89,
title = "Survey of practicing cardiologists in maryland on their choice of thrombolytic therapy for acute myocardial infarction",
abstract = "In November 1990, we surveyed 160 practicing community cardiologists in the state of Maryland and 20 academic cardiologists at the University of Maryland Medical Center to determine each individual's preference for aggressive versus nonaggressive therapy for various presentations of acute myocardial infarction. The survey was repeated in April 1991 following a report of the results of the Third International Study of Infarct Survival. All 100 responding cardiologists chose aggressive therapy to manage an early (<2 hours) acute anterior myocardial infarction in a 50-yearold patient. However, less aggressive therapy was chosen by many community cardiologists for management of early inferior acute myocardial infarction or for elderly patients. Most community cardiologists chose tissue plasminogen activator as their thrombolytic drug of choice, whereas university cardiologists favored streptokinase. Although there were substantial shifts in choice of thrombolytic agent on the repeat survey, most community physicians still chose tissue plasminogen activator over the less expensive streptokinase.",
author = "Plotnick, {Gary D.} and Ziskind, {Andrew A.} and Vogel, {Robert A.}",
year = "1992",
month = "2",
day = "1",
doi = "10.1016/0002-9149(92)90228-Q",
language = "English (US)",
volume = "69",
pages = "327--330",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Survey of practicing cardiologists in maryland on their choice of thrombolytic therapy for acute myocardial infarction

AU - Plotnick, Gary D.

AU - Ziskind, Andrew A.

AU - Vogel, Robert A.

PY - 1992/2/1

Y1 - 1992/2/1

N2 - In November 1990, we surveyed 160 practicing community cardiologists in the state of Maryland and 20 academic cardiologists at the University of Maryland Medical Center to determine each individual's preference for aggressive versus nonaggressive therapy for various presentations of acute myocardial infarction. The survey was repeated in April 1991 following a report of the results of the Third International Study of Infarct Survival. All 100 responding cardiologists chose aggressive therapy to manage an early (<2 hours) acute anterior myocardial infarction in a 50-yearold patient. However, less aggressive therapy was chosen by many community cardiologists for management of early inferior acute myocardial infarction or for elderly patients. Most community cardiologists chose tissue plasminogen activator as their thrombolytic drug of choice, whereas university cardiologists favored streptokinase. Although there were substantial shifts in choice of thrombolytic agent on the repeat survey, most community physicians still chose tissue plasminogen activator over the less expensive streptokinase.

AB - In November 1990, we surveyed 160 practicing community cardiologists in the state of Maryland and 20 academic cardiologists at the University of Maryland Medical Center to determine each individual's preference for aggressive versus nonaggressive therapy for various presentations of acute myocardial infarction. The survey was repeated in April 1991 following a report of the results of the Third International Study of Infarct Survival. All 100 responding cardiologists chose aggressive therapy to manage an early (<2 hours) acute anterior myocardial infarction in a 50-yearold patient. However, less aggressive therapy was chosen by many community cardiologists for management of early inferior acute myocardial infarction or for elderly patients. Most community cardiologists chose tissue plasminogen activator as their thrombolytic drug of choice, whereas university cardiologists favored streptokinase. Although there were substantial shifts in choice of thrombolytic agent on the repeat survey, most community physicians still chose tissue plasminogen activator over the less expensive streptokinase.

UR - http://www.scopus.com/inward/record.url?scp=0026587662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026587662&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(92)90228-Q

DO - 10.1016/0002-9149(92)90228-Q

M3 - Article

C2 - 1734643

AN - SCOPUS:0026587662

VL - 69

SP - 327

EP - 330

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -